Blake Jeffrey Grayson Sells 6,500 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson sold 6,500 shares of Docusign stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $71.20, for a total value of $462,800.00. Following the sale, the chief financial officer directly owned 105,660 shares in the company, valued at approximately $7,522,992. This trade represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Blake Jeffrey Grayson also recently made the following trade(s):

• On Wednesday, September 17th, Blake Jeffrey Grayson sold 9,509 shares of Docusign stock. The shares were sold at an average price of $83.10, for a total value of $790,197.90.

Docusign Trading Up 2.4%

Shares of DOCU stock opened at $69.73 on Friday. Docusign Inc. has a 12 month low of $62.66 and a 12 month high of $107.86. The company has a market capitalization of $14.02 billion, a P/E ratio of 52.43, a P/E/G ratio of 3.39 and a beta of 1.02. The stock has a 50 day moving average of $76.17 and a two-hundred day moving average of $79.09.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. The business had revenue of $800.64 million for the quarter, compared to analysts’ expectations of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.Docusign’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Sell-side analysts predict that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Wealth Enhancement Advisory Services LLC raised its position in Docusign by 17.9% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 17,215 shares of the company’s stock valued at $1,548,000 after purchasing an additional 2,612 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in shares of Docusign by 153.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company’s stock valued at $37,000 after buying an additional 274 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Docusign by 35,572.1% in the first quarter. GAMMA Investing LLC now owns 286,447 shares of the company’s stock valued at $23,317,000 after buying an additional 285,644 shares during the last quarter. Parallel Advisors LLC raised its holdings in shares of Docusign by 71.8% in the first quarter. Parallel Advisors LLC now owns 4,764 shares of the company’s stock valued at $388,000 after buying an additional 1,991 shares during the last quarter. Finally, RFG Advisory LLC acquired a new position in Docusign during the 1st quarter worth about $274,000. 77.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on DOCU shares. Royal Bank Of Canada raised their price objective on shares of Docusign from $90.00 to $95.00 and gave the stock a “sector perform” rating in a report on Friday, September 5th. Morgan Stanley increased their price target on shares of Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, September 8th. UBS Group set a $95.00 price objective on Docusign in a report on Friday, September 5th. Evercore ISI increased their target price on Docusign from $90.00 to $92.00 and gave the stock an “in-line” rating in a report on Friday, September 5th. Finally, JPMorgan Chase & Co. boosted their price target on Docusign from $77.00 to $80.00 and gave the company a “neutral” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fifteen have issued a Hold rating to the company. According to MarketBeat, Docusign presently has an average rating of “Hold” and a consensus price target of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.